✦ LIBER ✦
A randomized, double-blind, placebo-controlled study with pegylated recombinant human mekaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy, for adults with de novo acute myeloid leukemia: E. Archimbaud, O.G. Ottmann, J.A. Liu Yin, et al. Blood 94:3694–3701, 1999
✍ Scribed by Sunny Dzik
- Book ID
- 114268100
- Publisher
- Elsevier Science
- Year
- 2000
- Tongue
- English
- Weight
- 122 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1532-9496
No coin nor oath required. For personal study only.